Revised forecast
Fiscal year ending March 2027 · Full yearPrevious forecast published 14 May 2026 (the previous figure for earnings per share was announced on 6 August 2026)The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
This reflects lower revenue from the transfer of shares in the IFA business subsidiary and the transfer of a business operated by a consolidated subsidiary, temporarily weak revenue in the Wellness Business in the third quarter, lower selling, general and administrative expenses mainly due to lower personnel expenses, higher preparation costs for IFMC.-related products for the next fiscal year, and tax expenses of a consolidated subsidiary and an extraordinary loss in the first quarter.
Extraordinary loss in the first quarter (amount not disclosed)
| Item | Details |
|---|---|
| Net Sales | ¥2,608 million → ¥2,502 million（-4.1%） |
| Operating profit | ¥71 million → ¥85 million（+19.5%） |
| Ordinary income | ¥40 million → ¥51 million（+25.5%） |
| Profit attributable to owners of the parent | ¥12 million → ¥2 million（-80.6%） |
| Net income per share | ¥7.99 / sen → ¥1.5 / sen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Publication date of previous forecast | 14 May 2026 (the previous figure for earnings per share was announced on 6 August 2026) |
| Previous-period results | Revenue ¥2,419 million, operating profit -¥123 million, ordinary profit -¥160 million, net income attributable to owners of the parent -¥241 million, earnings per share -¥159.28 |
| Reason for the revision | This reflects lower revenue from the transfer of shares in the IFA business subsidiary and the transfer of a business operated by a consolidated subsidiary, temporarily weak revenue in the Wellness Business in the third quarter, lower selling, general and administrative expenses mainly due to lower personnel expenses, higher preparation costs for IFMC.-related products for the next fiscal year, and tax expenses of a consolidated subsidiary and an extraordinary loss in the first quarter. |
| Details and amount of extraordinary loss | Extraordinary loss in the first quarter (amount not disclosed) |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The revenue forecast was revised downward due to the transfer of the IFA business subsidiary, the transfer of a business operated by a consolidated subsidiary, and an expected slowdown in the Wellness Business in the third quarter. Operating profit and ordinary profit were revised upward due to lower selling, general and administrative expenses, mainly personnel expenses, while net income was revised downward to reflect tax expenses of a consolidated subsidiary and an extraordinary loss in the first quarter.